Cargando…
Treatment of Fatty Liver Disease: The Present and the Future
Non-alcoholic fatty liver disease (NAFLD) progressing to non-alcoholic steatohepatitis (NASH), cirrhosis, end-stage liver disease (ESRD), and hepatocellular carcinoma (HCC) is emerging as a global epidemic. Obesity, diabetes, and metabolic syndrome are some of the leading risk factors for NAFLD. The...
Autores principales: | Ramanan, Sruthi Priyavadhana, Mohamed, Mohamed Wael F, Aung, Su Sandi, Sange, Ibrahim, Hamid, Pousette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883529/ https://www.ncbi.nlm.nih.gov/pubmed/33614318 http://dx.doi.org/10.7759/cureus.12713 |
Ejemplares similares
-
Role, Effectiveness, and Outcome of Decompressive Craniectomy for Cerebral Venous and Dural Sinus Thrombosis (CVST): Is Surgery Really an Option?
por: Mohamed, Mohamed Wael F, et al.
Publicado: (2020) -
Celiac Disease and the Autoimmune Web of Endocrinopathies
por: Sange, Ibrahim, et al.
Publicado: (2020) -
Sickle Cell Disease and the Respiratory System: A Tangential Perspective to the Hematopulmonological Dilemma
por: Sange, Ibrahim, et al.
Publicado: (2021) -
Stroke and Fabry Disease: A Review of Literature
por: Mishra, Vinayak, et al.
Publicado: (2020) -
The Promise of the Zebrafish Model for Parkinson’s Disease: Today’s Science and Tomorrow’s Treatment
por: Razali, Khairiah, et al.
Publicado: (2021)